Saturday, March 3, 2012

Chemotherapy, ORT do not prevent CNS progression in ocular lymphoma study.

2004 SEP 7 - (NewsRx.com & NewsRx.net) -- Researchers from the U.S. reported that chemotherapy and/or ocular radiotherapy failed to prevent central nervous system (CNS) progression in study patients with primary ocular lymphoma; however, patients had a significantly improved survival rate if the ocular disease was identified and treated before CNS progression.

"Primary ocular lymphoma (POL), a lymphoma of the globe, is a restricted form of primary central nervous system lymphoma (PCNSL) that often progresses to the brain and meninges; frequently it is misdiagnosed until central nervous system (CNS) lymphoma develops," wrote A. Hormigo and colleagues.

The …

No comments:

Post a Comment